JD Supra: Mergers

MARCH 29, 2024

On February 22, 2024, the Minnesota legislature introduced a bill (SF-4392 and companion bill HR-4206) which seeks to curb the control and acquisition over certain healthcare providers by private equity companies and real estate investment trusts (REITs). By: Lathrop GPM

Healthcare 201

Healthcare Investment Private Equity Equities 201

JD Supra: Mergers

OCTOBER 11, 2024

In a recent episode of the Heart of Healthcare podcast, co-hosts Michael T. Esquivel and Halle Tecco, sat down with Federal Trade Commission (FTC) Chair Lina Khan, who offered her perspective on the intersection of antitrust enforcement and the healthcare industry. By: Fenwick & West LLP

Healthcare 177

Healthcare Trading 177

JD Supra: Mergers

FEBRUARY 28, 2024

In the second week of January, Goodwin and KPMG convened innovators, practitioners, regulators, and others for our annual symposium on the future of life sciences and healthcare. Morgan Healthcare Conference in San Francisco. This marked the fifth year that Goodwin co-hosted the symposium, which takes place during the annual J.P.

Healthcare 205

Healthcare IPO M&A 205

JD Supra: Mergers

MAY 1, 2024

Companies should prepare for increased regulatory scrutiny into healthcare transactions and increased emphasis on compliance programs. We are tracking the inquiry and summarize here the. By: Latham & Watkins LLP

Healthcare 177

Healthcare Corporation Trading 177

JD Supra: Mergers

MARCH 12, 2024

2023 saw a significant uptick in antitrust scrutiny and enforcement, particularly in the healthcare space.

Healthcare 192

Healthcare Private Equity Mergers Equities 192

JD Supra: Mergers

JUNE 18, 2024

The following states have proposed, but not passed, additional state healthcare transaction notification laws. By: Goodwin

Healthcare 171

Healthcare 171

JD Supra: Mergers

SEPTEMBER 20, 2024

In the second quarter, federal and state antitrust enforcers continued their intense scrutiny of consolidation in the healthcare market by implementing new initiatives and laws designed to gather additional information regarding transactions and conduct in the space. By: Goodwin

Healthcare 183

Healthcare 183

JD Supra: Mergers

JULY 9, 2024

Exiting a business, whether you are a serial entrepreneur looking to move on to the next project or a healthcare provider like a physician or therapist who has nurtured your practice for decades, can be difficult. After all, corporate transactions are complex affairs that often hang on small details.

Healthcare 188

Healthcare Corporation Business 188

JD Supra: Mergers

AUGUST 2, 2024

Investment in the healthcare industry requires careful consideration, as it involves numerous distinct areas of the law. Venable's Private Equity Investment in Healthcare webinar series explores the unique issues and timely developments that shape deals within the industry. By: Venable LLP

Private Equity 171

Private Equity Healthcare Equities Investment 171

JD Supra: Mergers

JUNE 3, 2024

Rapid digitalization in the health industry is set to drive M&A across the region - Digitalization is reshaping the global healthcare industry as demand for personalized, more accessible care fuels innovative market solutions. This fresh prioritization prompted a surge of investment and innovation, with the value of the global digital.

Healthcare 177

Healthcare M&A Investment Management 177

JD Supra: Mergers

AUGUST 1, 2024

At the end of last year, Holland & Knight predicted that "the current enforcement environment will continue into 2024 and will focus heavily on the healthcare industry, along with private equity transactions or 'roll-ups.' 15, 2023.)

Private Equity 171

Private Equity Healthcare Equities 171

JD Supra: Mergers

MAY 9, 2024

Knox Lane has announced the acquisition of All Star Healthcare Solutions. By: McGuireWoods LLP

Healthcare 152

Healthcare Private Equity Hospitality Equities 152

JD Supra: Mergers

JUNE 18, 2024

healthcare space has grown dramatically in recent years, in large part based on the significant increase in private investment. This has not gone unnoticed, and U.S.

Healthcare 159

Healthcare Investment 159

JD Supra: Mergers

OCTOBER 21, 2024

In the healthcare mergers and acquisitions (M&A) market, while deal volumes varied across different sectors, by and large the sure and steady pace of deal volume in Q2 continued into Q3.

Healthcare 171

Healthcare Mergers and Acquisitions M&A Mergers 171

JD Supra: Mergers

SEPTEMBER 17, 2024

Investment in the healthcare industry requires careful consideration, as it involves numerous distinct areas of the law. Venable's Private Equity Investment in Healthcare webinar series explores the unique issues and timely developments that shape deals within the industry. By: Venable LLP

Healthcare 183

Healthcare Private Equity Equities Investment 183

JD Supra: Mergers

NOVEMBER 10, 2023

After steadying during Q2, it appears the overall volume of deals in the healthcare industry declined in Q3 compared with Q2, and year-to-date 2023 is still down from last year.

Healthcare 188

Healthcare IT 188

JD Supra: Mergers

MAY 21, 2024

Earlier this year, Indiana joined a growing number of states by enacting a new notification requirement for certain healthcare transactions.

Healthcare 192

Healthcare Private Equity Equities Investors 192

JD Supra: Mergers

JULY 2, 2024

Triton Pacific Healthcare Partners has announced the closing of its sale of BioMatrix Specialty Infusion Pharmacy to Frazier Healthcare Partners. BioMatrix, founded in 2001 and based in Plantation, Florida, is a provider of specialty infusion services in the United States. By: McGuireWoods LLP

Healthcare 152

Healthcare Private Equity Equities Sale 152

JD Supra: Mergers

OCTOBER 3, 2024

3129), which would have required private equity funds and hedge funds to obtain consent before entering into certain healthcare transactions. 3129 into law, certain investments in a healthcare facility, provider, or provider. Gavin Newsom vetoed California Assembly Bill 3129 (A.B. The closely monitored legislative effort behind A.B.

Healthcare 165

Healthcare Investment Private Equity Consulting 165

JD Supra: Mergers

OCTOBER 18, 2023

The healthcare industry is no stranger to mergers and acquisitions (M&A). Over the years, consolidation has played a significant role in reshaping the healthcare landscape, driven by factors such as regulatory changes, technological advancements, and the pursuit of economies of scale. By: Ankura

Healthcare 171

Healthcare Mergers Acquisitions Mergers and Acquisitions 171

JD Supra: Mergers

MAY 21, 2024

BRight Minds in Healthcare Delivery invites industry leaders to discuss the latest trends and hot topics in healthcare strategy, delivery, and innovation. Listen in as industry experts, thought leaders, and innovators consider how to disrupt the way that millions of Americans receive healthcare. By: Blank Rome LLP

Healthcare 152

Healthcare Investment 152

JD Supra: Mergers

JUNE 18, 2024

The California Office of Health Care Affordability and the California Attorney General both require entities to provide notification about certain healthcare transactions. We provide details about both sets of requirements below. By: Goodwin

Healthcare 165

Healthcare 165

JD Supra: Mergers

AUGUST 29, 2024

Driven by a growing wave of enforcer skepticism toward further healthcare consolidation, some state legislatures have begun to propose “mini-HSR” laws explicitly targeting healthcare transactions involving private equity firms or sponsors. By: Morgan Lewis

Private Equity 171

Private Equity Healthcare Equities 171

JD Supra: Mergers

MARCH 12, 2024

Private equity acquisitions in healthcare will likely face increased scrutiny from multiple federal departments, as well as from state antitrust enforcement officials. By: Mayer Brown

Private Equity 183

Private Equity Healthcare Equities Acquisitions 183

JD Supra: Mergers

JUNE 18, 2024

Key Takeaways -.Requires

Healthcare 171

Healthcare Mergers and Acquisitions Mergers Acquisitions 171

JD Supra: Mergers

MARCH 28, 2024

While private equity (PE) investments in healthcare have long been subject to scrutiny, as PE investment in healthcare has grown sizably over the last decade, so too has the concern from federal and state regulatory bodies surrounding this type of investment.

Healthcare 171

Healthcare Investment Private Equity Equities 171

JD Supra: Mergers

OCTOBER 9, 2023

Growing state-level oversight of M&A and other strategic transactions for healthcare provider businesses will impact growth strategies across major markets.

Healthcare 177

Healthcare Collaboration M&A Investors 177

JD Supra: Mergers

OCTOBER 14, 2024

2024 has been an eventful year for federal and state antitrust enforcement in healthcare with many in the industry wondering where do we go from here in 2025.

Healthcare 183

Healthcare 183

JD Supra: Mergers

OCTOBER 11, 2024

State legislatures across the country are beginning to consider and debate the pros and cons of passing laws aimed at regulating private equity’s role in the healthcare industry. According to an article in the Wall Street Journal on April 18, 2024, 12 states have already passed legislation regulating private equity involvement in healthcare.

Private Equity 177

Private Equity Healthcare Equities 177

JD Supra: Mergers

AUGUST 15, 2024

healthcare industry has weathered the storm over the past couple of years, we may be reaching calmer waters in the coming months. With that backdrop, navigating the healthcare M&A landscape continues to be increasingly challenging, especially with an ever-evolving regulatory landscape. Although the U.S. Dry powder held by U.S.

Private Equity 177

Private Equity Healthcare Equities M&A 177

JD Supra: Mergers

JUNE 21, 2024

Requires parties to seek approval from the Oregon Health Authority (“OHA”) for certain healthcare mergers, acquisitions, affiliations and other transactions involving “health care entities”.Under Key Takeaways -.Requires

Healthcare 165

Healthcare Mergers and Acquisitions Mergers Acquisitions 165

JD Supra: Mergers

MAY 17, 2024

On May 9, the Department of Justice’s (DOJ) Antitrust Division announced the creation of a new task force, the Task Force on Health Care Monopolies and Collusion (HCMC), focusing on antitrust enforcement in the healthcare industry. By: Bass, Berry & Sims PLC

Healthcare 165

Healthcare 165

JD Supra: Mergers

JUNE 20, 2024

Key Takeaways -.Requires The MN AG is empowered to bring an action to block a given.

Healthcare 165

Healthcare Mergers and Acquisitions Mergers Sale 165

JD Supra: Mergers

SEPTEMBER 26, 2024

The California Legislature recently passed Assembly Bill 3129 (“AB 3129” or the “Bill”), which, if signed by California Governor Gavin Newsom, would increase oversight of healthcare entity transactions involving private equity investment. Governor Newsom has until September 30, 2024, to sign or veto the Bill. By: Arnall Golden Gregory LLP

Private Equity 177

Private Equity Healthcare Equities Investment 177

JD Supra: Mergers

OCTOBER 18, 2024

State-level oversight of M&A and other strategic transactions involving healthcare is continuing to expand into new markets and impact growth strategies.

Healthcare 165

Healthcare Collaboration M&A Investors 165

JD Supra: Mergers

NOVEMBER 14, 2023

Starting January 1, 2024, healthcare facilities and provider organizations engaging in certain transactions in Illinois, such as mergers and acquisitions, will have new reporting requirements.

Healthcare 165

Healthcare Mergers and Acquisitions Mergers Acquisitions 165